We are live on ! Find out more
AC

AltraVue Capital Portfolio holdings

AUM $1.16B
1-Year Est. Return 46.45%
This Fund
S&P 500
This Quarter Est. Return
+1.49%
1 Year Est. Return
+46.45%
3 Year Est. Return
+174.8%
5 Year Est. Return
+275.78%
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$7.82M
Cap. Flow
+$12.5M
Cap. Flow %
1.03%
Top 10 Hldgs %
64.92%
Holding
27
New
2
Increased
5
Reduced
16
Closed

Top Sells

Rank Stock Value
1
AGX icon
Argan
AGX
+$33.2M
2
IESC icon
IES Holdings
IESC
+$9.5M
3
SNEX icon
StoneX
SNEX
+$196K
4
VSEC icon
VSE Corp
VSEC
+$152K
5
AGYS icon
Agilysys
AGYS
+$152K

Sector Composition

Rank Sector Weight
1 Financials 26.44%
2 Industrials 23.6%
3 Technology 20.5%
4 Consumer Discretionary 14.54%
5 Healthcare 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYAX
26
Nayax
NYAX
$2.49B
$11.6M 0.96%
+229,713
New +$10.4M
JBI icon
27
Janus International
JBI
$694M
$9.94M 0.82%
1,520,530
-5,480
-0.4% -$42.7K

Similar funds

AltraVue Capital's Q4 2025 Portfolio in Review

As of Q4 2025, AltraVue Capital held 27 positions worth $1.21B, up 0.65% from $1.21B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

AltraVue Capital's Q4 2025 filing shows 2 new, 5 increased and 16 reduced positions. Its largest new stake was NB Bancorp: 693,000 shares worth $13.7M. The largest sale was Argan, an estimated $33.2M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 24% a quarter earlier, followed by Industrials and Technology.

  • AltraVue Capital's largest Q4 2025 buy was NB Bancorp: 693,000 shares worth $13.7M.
  • AltraVue Capital added most to Triumph Financial Inc in Q4 2025, an estimated $15.3M increase.
  • AltraVue Capital's biggest Q4 2025 reduction was Argan, cutting an estimated $33.2M.
  • AltraVue Capital's ten largest holdings make up 65% of its $1.21B portfolio in Q4 2025.
  • AltraVue Capital opened 2 new positions and closed 0 in Q4 2025.
  • AltraVue Capital's portfolio value rose 0.65% quarter-over-quarter to $1.21B.

Based on AltraVue Capital's 13F filing for Q4 2025, filed 11 Feb 2026.